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a b s t r a c t
Background: Post polio syndrome is a rare disease that occurs decades after polio virus
infection. Repetitive transcranial magnetic stimulation (rTMS) is a treatment option with
proved effectiveness in drug resistant depression. Possibly it can be helpful in therapy of
other neurological diseases including post polio syndrome.
Objective: To describe a case of patient diagnosed with post polio syndrome who was treated
with rTMS stimulation with a good effect.
Methods: Patient had rTMS stimulation of left prefrontal cortex twice a week for an eight
weeks. Patient's health status was evaluated before treatment, after last rTMS session and
after three months from the end of the treatment.
Results: Improvement of fatigue score, mood disturbances and motor functions was ob-
served after treatment.
Conclusion: rTMS can be an effective method in treatment of post polio syndrome but further
studies with larger group need to be done to conﬁrm that data.
© 2017 Published by Elsevier Sp. z o.o. on behalf of Polish Neurological Society.
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Post polio syndrome (PPS) can occur even 30–40 years after
acute polio virus infection. The most characteristic symptoms
are slowly progressive muscle weakness and atrophy that can* Corresponding author.
E-mail address: zpastuszak@imdik.pan.pl (Ż. Pastuszak).
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0028-3843/© 2017 Published by Elsevier Sp. z o.o. on behalf of Polish Nbe observed in muscles clinically affected and nonaffected
during primary polio infection. Patients often claim at muscle
and joints pain as well as chronic fatigue, mood disturbances,
problems with sleeping, memory and concentration [1]. PPS
symptoms can be induced by infectious, injuries, operations or
intensive physical activity. Those symptoms have severe
impact on daily activity making patients severe disabled [2]. Inio syndrome; tDCS, transcranial direct current stimulation.
eurological Society.
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amyotrophic lateral sclerosis, cervical spondylosis, cord
tumors as well as systemic conditions that may be a cause
of fatigue. Unfortunately there is no cure for PPS. The most
important is rehabilitation because it can improve the quality
of life and slow the process of muscles atrophy. Resting
affected limb with the orthopedic equipment can be also
effective. There were attempts of treatment with pyridostig-
mine and amantadine or immunoglobulins but their effec-
tiveness in PPS was not conﬁrmed [3]. In presented study we
described the case of patient who was treated with repetitive
transcranial magnetic stimulation (rTMS) with satisfying
effect.
2. Method
In presented work we described 58 years old female with
hypertension who survived from polio infection at age of 6
years. She complained of progressive general weakness,
problems with sleeping and concentration, joints pain
accompanied by mood deterioration. Symptoms started ﬁve
years earlier after respiratory tract infection. Due to polio she
had paresis of left leg and walk on crutches since that time.
Now she claims that also right limbs seem to be disabled from
about four years. In computer tomography (CT) there were no
abnormalities. Laboratory tests were also normal. Electro-
neurography (ENG) did not reveal any abnormalities. In
electromyography (EMG) there were features of chronic
denervation in muscle of both arms and right leg. No voluntary
activity in left leg muscles was observed. Signs of acute
denervation were not noted despite of the fact that her
neurological state was deteriorating. Diagnosis of PPS was
established based on criteria made by the European Federation
of Neurological Societies (EFNS) [4]. Due to the joints pain and
sleep disturbances, patient was treated with amitriptyline
25 mg once a day and regular rehabilitation for four years with
mild effect.
Patient was treated with the use of repetitive transcranial
magnetic stimulation (rTMS, MagPro R20) twice a week for a
month (eight sessions). rTMS frequency was 5 Hz and during
one session 750 stimuli was given to the left prefrontal cortex.
We had chosen that area of brain due to the fact that fatigue,
mood deterioration, general weakness were the most trouble-
some symptoms in case of that patient. Moreover we had
made the hypothesis that rTMS stimulation may have impact
on that structure in brain and motor function due to the fact
that prefrontal cortex is located near to motor cortex area.
Parameters of stimulation were determined based on litera-Table 1 – rTMS treatment compared to results before that ther
Test Results before treatment Results a
25 foot walk test 9.76 s 7
SDMT test 76 points 8
Hamilton test 4 points 1
Beck test 15 points 4
MFIS scale 39 points 3
FSS scale 49 points 4
VAF scale 4 points 6ture data and were similar to those used in treatment of
Parkinson disease as well as brain stroke (due to the fact that
there is lack of data evaluating the best parameters of rTMS in
PPS) [5,6]. Patient's motor functions were evaluated with 25
foot walk test (25 FWT) [7]. Visuospatial attention and
information processing speed were evaluated with the simple
digit modality test (SDMT, oral version of the test) [8]. Mood
was evaluated with the use of Hamilton and Beck tests [9,10].
Modiﬁed fatigue impact scale (MFIS), fatigue severe scale (FSS)
and visual analog fatigue scale (VAFS) were used to investigate
impact of fatigue on patient's daily activity [11–13]. Tests were
made before treatment, after last rTMS session and three
months after end of treatment. Pain and sleep were not
evaluated with the use of speciﬁc tests due to the fact that
patient was treated with amitryptylinum because of that
symptoms.
3. Results
In presented study improvement was observed in all
performed tests after rTMS treatment compared to results
before that therapy. That positive effect was still present after
three months from the end of treatment (Table 1).
4. Discussion
PPS is a rare condition with unknown etiology. Effective
treatment also remains elusive. rTMS can be a therapeutic
option, that may improve patients' quality of life, reduce
fatigue symptoms or mood disturbances. Repetitive transcra-
nial magnetic stimulation (rTMS) is a treatment option with
proved effectiveness in many neurological and psychiatric
disorders especially in drug resistant depression. Magnetic
ﬁeld generated by rTMS penetrate skin of the scalp and
inﬁltrate brain tissues, causing neurons depolarization or
hyperpolarization. Depending on the stimulation frequency
rTMS can stimuli or inhibit brain cortex [14]. There is no data
describing rTMS effectiveness in PPS. Left prefrontal cortex
was stimulated with the use of rTMS in many studies with
patients suffered from mood disturbances and neuropathic
pain. It is also accepted in treatment of drug resistant
depression by the Food and Drug Administration (FDA)
[14,15]. In study with group of 17 patients with drug resistant
depression, improvement of psychiatric condition was seen in
case of 11 people after ﬁve rTMS sessions with 10 Hz frequency
[16]. Herman in his analysis from 2006 year with group of 877
patients with depression, revealed that in group treated withapy.
fter treatment Results three months after treatment
.36 s 7.82 s
8 points 82 points
 point 2 points
 points 6 points
1 points 30 points
4 points 44 points
 points 6 points
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33.6% compared to 17.4% in placebo group [17]. In another
study, rTMS also improved cognitive and motor function in
healthy volunteers. In those patients cerebral blood ﬂow was
higher in brain areas connected with attention, motor
functions, concentration and ability to learn new tasks [18].
In review of literature, Lefaucheur analyzed effectiveness of
rTMS and transcranial direct current stimulation (tDCS) in
treatment of fatigue in patients with multiple sclerosis,
ﬁbromyalgia, chronic fatigue syndrome, post-polio syndrome,
Parkinson's disease and amyotrophic lateral sclerosis. The
primary sensorimotor cortex, the dorsolateral prefrontal
cortex and the posterior parietal cortex were the areas of
stimulation in presented work. Non-invasive brain stimula-
tion seemed to be a promising therapeutic option in those
patients but further study with larger groups of patients need
to be done [19]. There is also a sufﬁcient body of evidence to
accept the analgesic effect of high-frequency rTMS of the
primary motor cortex contralateral to the pain [20].
Based on that data we hypothesized that stimulation of left
prefrontal cortex may be effective in case of PPS symptoms like
depression, chronic fatigue and problems with concentration.
Magnetic ﬁeld inﬁltrates brain tissues to a depth of 2 cm and
causes neurons depolarization. Similar changes were also
observed in adjoining areas of the brain probably due to
synaptic modulation process. rTMS stimulation increases
dopamine secretion in mesolimbic system and stimulates
neurogenesis due to release of neuroprotective factors [21]. It
also stimulates signal transduction in cortico-subcortical
pathways and modulates neurons activity in subcortical areas.
In case of PPS patients motoneurones damage in spine frontal
horns results in motor problems, limbs paresis and muscle
atrophy. Other symptoms like chronic fatigue, mood distur-
bances, problems with sleeping cognitive performance deteri-
oration, memory and concentration impairment are probably
related to reticular activating system (RAS) damage. RAS is
connected with regulating wakefulness and sleep–wake
transitions. In histopathological examinations severe abnor-
malities in brainstems of PPS patients were also observed [22].
In presented study after rTMS stimulation great improve-
ment was observed in all performed tests evaluating mood
disturbances, visuospatial attention, information processing
speed and fatigue syndrome severity. Patient claimed that her
daily activity improved, she had better mood and felt less tired
during a day. Her family also noticed neurological state
improvement. Better result of 25 foot walk test after month of
rTMS treatment was surprising. Patient was disabled due to
left leg paresis and walk on crutches since childhood. She
claimed that also right limb seemed to be disabled from about
four years. Her problems with walking were connected to front
spine hors damage, that were not stimulated in that study.
Improvement of motor function may be a result of less severe
fatigue symptoms or rTMS analgesic effects. Prefrontal cortex
is located near to motor cortex area and rTMS stimulation may
have impact on that structure in brain and motor function.
Many studies revealed that chronic fatigue symptoms may
ﬂuctuate during a day and that effect can have impact on 25
foot walk test results. That positive effect of rTMS on PPS
symptoms severity lasted for three months in presented
patient. Further study with larger group of patients and withsham (placebo) rTMS need to be done to conﬁrm rTMS
effectiveness and safety in PPS patients.
5. Conclusion
PPS is a rare disease with elusive etiology. There is no effective
treatment for PPS symptoms. rTMS can be a treatment option
for those patients that can reduce fatigue, improve mood
disturbances or even motor functions. Although PPS is a very
rare disease, further studies with larger group of patients and
with sham rTMS need to be done to evaluate effectiveness and
safety of that treatment option in those people.
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